Bryn Mawr Trust CO Agios Pharmaceuticals, Inc. Transaction History
Bryn Mawr Trust CO
- $5.25 Billion
- Q1 2025
A detailed history of Bryn Mawr Trust CO transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 2,111 shares of AGIO stock, worth $63,562. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,111Holding current value
$63,562% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
60.1MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$172 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$169 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$146 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$106 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$73.8 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.65B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...